Granulomatous mastitis (GM) is a non-infectious inflammatory breast condition typically affecting young women, often following breastfeeding. Management of GM often begins with anti-inflammatory medications and antibiotics. Steroids, particularly intralesional corticosteroids, are considered the first-line treatment for GM due to their rapid anti-inflammatory and immunosuppressive effects. Steroids help control symptoms such as painful lumps, swelling, and redness. Steroids' effectiveness in providing symptom relief minimizes the need for more invasive treatments such as surgery.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Clinical Resolution Rate at 12 Weeks Post-Treatment And Reduction in Size
Timeframe: 12 weeks (±1 week) after intralesional steroid injection per participant
Clinical Resolution Rate at 12 Weeks Post-Treatment and Reduction in Lesion Size
Timeframe: 12 weeks (±1 week) after intralesional steroid injection per participant